'Virologic suppression' presentation slideshows

HIV UPDATE 2013

HIV UPDATE 2013. Ronald G Nahass , MD, FACP, FIDSA President ID CARE Medical Director AETC Clinical Professor RWJ Medical School. DISCLOSURES.

509 views • 42 slides

HIV Neuropsychiatric Issues

HIV Neuropsychiatric Issues. Warren Y.K. Ng, M.D. NYPH/ Harlem Hospital HIV Mental Health Training Project Columbia University. 28 th Year of AIDS World AIDS Day Dec 1, 2009. Twenty-Five year trends in HIV and AIDS cases 1984-2007. Good News and Bad News. Steven Deeks MD IAS-USA May 2009

872 views • 36 slides

Immediate Antiretroviral Therapy for Better Patient Health and HIV Prevention

Immediate Antiretroviral Therapy for Better Patient Health and HIV Prevention. Oliver Bacon, MD, MPH 2 February 2016. Disclosures.

205 views • 20 slides

IeDEA 2010 San Francisco, CA

The Immunologic Efficacy of Antiretroviral Therapy for HIV-infected Patients in North America and Africa. IeDEA 2010 San Francisco, CA. Acknowledgements. East Africa Jeffery Martin Steven Deeks Mwebesa Bosco Bwana Nicholas Musinguzi David Bangsberg Philippa Easterbrook Agnes Kiragga

282 views • 16 slides

A P hase II non-comparative multicenter trial

TUPDB204. Efficacy and safety of r altegravir plus etravirine and darunavir/ritonavir in treatment-experienced patients with multidrug-resistant virus: 48-week results from the ANRS 139 TRIO trial. A P hase II non-comparative multicenter trial

214 views • 8 slides

Switch to FTC + ddI + EFV - ALIZE - Switch EFV to ETR

247 views • 7 slides

Switch studies in virologically suppressed patients

212 views • 7 slides

N: 81 35 14 7 6 2 1

SDC 3: Time until virologic suppression and failure. Duration until subsequent virological failure. Duration until first virological suppression. N: 81 35 14 7 6 2 1

108 views • 1 slides